Cargando…
Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives
Clopidogrel has significantly reduced the incidence of recurrent atherothrombotic events in patients with acute coronary syndrome (ACS) and in those undergoing percutaneous coronary intervention (PCI). However, recurrence events still remain, which may be partly due to inadequate platelet inhibition...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369137/ https://www.ncbi.nlm.nih.gov/pubmed/28335443 http://dx.doi.org/10.3390/ijerph14030301 |